McNeil gains OTC status for Rhinocort in US

2 April 2015 - Deborah Wilkes

Archived

McNeil Consumer Healthcare is set to launch AstraZeneca's Rhinocort (budesonide) nasal spray as an OTC medicine in the US.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: